Omada Health (NASDAQ:OMDA) Stock Gets Price Target Trim from Barclays

Omada Health (NASDAQ:OMDA) had its target price dropped by analysts at Barclays from $24.00 to $22.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 38.79% from the company’s previous close.

Several other research firms have also commented on OMDA. Canaccord Genuity Group increased their price objective on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. Needham & Company LLC restated a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research note on Friday, September 11th. JPMorgan Chase & Co. upped their target price on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Finally, Weiss Ratings downgraded Omada Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.33.

Omada Health Price Performance

Shares of NASDAQ OMDA traded down $3.10 during trading on Friday, hitting $15.85. The stock had a trading volume of 1,829,693 shares, compared to its average volume of 1,254,319. Omada Health has a 12 month low of $10.28 and a 12 month high of $25.45. The company has a market capitalization of $970.40 million, a PE ratio of 317.10 and a beta of 2.13. The firm has a fifty day moving average of $20.33 and a two-hundred day moving average of $17.74.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.02 by $0.08. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $91.31 million during the quarter. On average, equities analysts expect that Omada Health will post 0.09 earnings per share for the current fiscal year.

Insider Activity at Omada Health

In related news, President Wei-Li Shao sold 8,866 shares of the stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $25.02, for a total transaction of $221,827.32. Following the completion of the transaction, the president owned 307,372 shares in the company, valued at approximately $7,690,447.44. This represents a 2.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Steven Cook sold 15,235 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $25.03, for a total transaction of $381,332.05. Following the sale, the chief financial officer owned 187,209 shares of the company’s stock, valued at $4,685,841.27. This trade represents a 7.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 106,070 shares of company stock worth $2,462,621. 6.38% of the stock is owned by company insiders.

Institutional Investors Weigh In On Omada Health

Large investors have recently modified their holdings of the stock. China Universal Asset Management Co. Ltd. bought a new position in shares of Omada Health during the 3rd quarter worth $70,000. Sterling Capital Management LLC increased its holdings in Omada Health by 1,161.6% in the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock worth $33,000 after acquiring an additional 1,452 shares during the last quarter. Robeco Institutional Asset Management B.V. purchased a new stake in Omada Health in the 3rd quarter worth about $1,100,000. Counterpoint Mutual Funds LLC bought a new stake in Omada Health in the 3rd quarter valued at about $595,000. Finally, State of Alaska Department of Revenue bought a new stake in Omada Health in the 3rd quarter valued at about $59,000.

Key Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Revenue rose 34% year over year to $91 million, and total members grew 36% to a record 1.1 million. Omada also reported $7 million in net income versus a year-ago loss, higher gross margins, and $12 million in adjusted EBITDA. The company raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly earnings and revenue exceeded analyst estimates, reinforcing the company’s improving operating performance. Q3 Earnings and Revenues Beat Estimates
• Neutral Sentiment: Wells Fargo lowered its price target from $22 to $19 and maintained an equal-weight rating. The new target remains above the quoted share price, but the reduction signals more restrained expectations. Wells Fargo Recommendations
• Negative Sentiment: Zacks Research downgraded Omada from “strong buy” to “hold,” adding to the cautious analyst signals despite the earnings beat. Tickerreport coverage

About Omada Health

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.